Oppenheimer makes rare cuts to top US investment banks, backs alternative asset managers

Oppenheimer downgraded major U.S. investment banks—Goldman Sachs and Morgan Stanley—to “underperform” (from “perform”) and cut Citigroup and Bank of America to “perform” (from “outperform”), arguing valuations leave limited upside even if operating conditions remain favorable. The notes coincide with rate-hike jitters and have shares sliding (Morgan Stanley -1.36% pre-bell; Goldman -0.4% after hours). Oppenheimer recommends investors “sell large-cap investment banks” and instead buy alternative asset managers (e.g., Ares, Blackstone, KKR), pointing to overdone concerns around private-credit exposure and elevated redemptions.

Analysis

This is less a fundamental downgrade on earnings power than a valuation call on where the cycle’s marginal dollar of return is going next. Large-cap investment banks are now the cleanest expression of peak financials sentiment: they still have operating momentum, but the market has already paid for it, so any deceleration in ECM/M&A or trading could trigger multiple compression before the P&L shows up. The first-order loser is GS/MS; the second-order loser is the financials factor itself if investors start treating high-beta fee streams as late-cycle trades rather than secular compounders.

The more interesting setup is the dispersion trade inside “financials.” Alternative asset managers have lagged because investors are extrapolating private-credit stress into permanent fee impairment, but that concern is only damaging if it turns into realized defaults, NAV markdowns, or fundraising impairment. If credit remains contained, BX/KKR/ARES have a cleaner path to rerating than the banks because fee-related earnings are less tied to deal cycle noise and more to sticky AUM; that creates a 1-3 month catalyst path if the next reporting season shows no redemption spike.

Commercial banks like USB and PNC are a quieter relative winner only if the market starts rewarding balance-sheet conservatism and early-cycle NII normalization over capital-markets optionality. The contrarian miss is that private-credit fear may be over-discounted while bank optimism may be a bit late-cycle already. What would falsify the “alts over banks” view: an upswing in capital-markets activity, stronger advisory backlog, or a visible tick-up in direct-lending losses and redemption pressure over the next 1-2 quarters.

Key Decisions for Investors

• Pair trade: long BX/KKR/ARES basket vs short GS/MS for 1-3 months; thesis is multiple rerating in alts versus peak-cycle compression in capital-markets-heavy franchises. Stop if GS/MS guide to sustained revenue acceleration or if alts report redemption/credit losses that force fee cuts.
• If positioning for lower urgency, buy BX or KKR on a 2-4 week pullback and sell into any further selloff tied to generic private-credit headlines; risk/reward improves if reported fund flows remain stable and nonaccruals do not widen.
• Use USB and PNC as lower-beta longs only as a relative-value hedge against a financials drawdown, not as outright alpha bets; they work best if rates drift lower and credit stays benign over the next 6-12 months.
• Avoid chasing BAC/C on this downgrade spread: they have less direct upside from the analyst rotation and more sensitivity to flat NII and deposit competition; consider them as shorts only if bank earnings revisions start rolling over.
• Set a watch item on the next quarter’s direct-lending marks, redemption commentary, and fundraising trends for BX/KKR/ARES; if those are clean, the market is likely underestimating the durability of alternative managers' fee streams.